The global cell culture media market size is accounted at USD 7.68 billion in 2025 and is forecasted to hit around USD 20.23 billion by 2034, representing a CAGR of 11.42% from 2025 to 2034. The North America market size was estimated at USD 2.68 billion in 2024 and is expanding at a CAGR of 11.45% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cell Culture Media Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cell Culture Media Market Revenue and Volume Forecast, by Product
8.1.1. Serum-free Media
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Classical Media
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Stem Cell Culture Media
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Specialty Media
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Chemically Defined Media
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast
9.1. Cell Culture Media Market Revenue and Volume Forecast, by Application
9.1.1. Biopharmaceutical Production
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Diagnostics
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Drug Screening and Development
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Tissue Engineering and Regenerative Medicine
9.1.4.1. Market Revenue and Volume Forecast
10.1. Cell Culture Media Market Revenue and Volume Forecast, by Type
10.1.1. Liquid Media
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Semi-solid and Solid Media
10.1.2.1. Market Revenue and Volume Forecast
11.1. Cell Culture Media Market Revenue and Volume Forecast, by End-user
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Hospitals and Diagnostics Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Research and Academic Institutes
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product
12.1.2. Market Revenue and Volume Forecast, by Application
12.1.3. Market Revenue and Volume Forecast, by Type
12.1.4. Market Revenue and Volume Forecast, by End-user
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product
12.1.5.2. Market Revenue and Volume Forecast, by Application
12.1.5.3. Market Revenue and Volume Forecast, by Type
12.1.5.4. Market Revenue and Volume Forecast, by End-user
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product
12.1.6.2. Market Revenue and Volume Forecast, by Application
12.1.6.3. Market Revenue and Volume Forecast, by Type
12.1.6.4. Market Revenue and Volume Forecast, by End-user
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product
12.2.2. Market Revenue and Volume Forecast, by Application
12.2.3. Market Revenue and Volume Forecast, by Type
12.2.4. Market Revenue and Volume Forecast, by End-user
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product
12.2.5.2. Market Revenue and Volume Forecast, by Application
12.2.5.3. Market Revenue and Volume Forecast, by Type
12.2.5.4. Market Revenue and Volume Forecast, by End-user
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product
12.2.6.2. Market Revenue and Volume Forecast, by Application
12.2.6.3. Market Revenue and Volume Forecast, by Type
12.2.6.4. Market Revenue and Volume Forecast, by End-user
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product
12.2.7.2. Market Revenue and Volume Forecast, by Application
12.2.7.3. Market Revenue and Volume Forecast, by Type
12.2.7.4. Market Revenue and Volume Forecast, by End-user
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product
12.2.8.2. Market Revenue and Volume Forecast, by Application
12.2.8.3. Market Revenue and Volume Forecast, by Type
12.2.8.4. Market Revenue and Volume Forecast, by End-user
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product
12.3.2. Market Revenue and Volume Forecast, by Application
12.3.3. Market Revenue and Volume Forecast, by Type
12.3.4. Market Revenue and Volume Forecast, by End-user
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product
12.3.5.2. Market Revenue and Volume Forecast, by Application
12.3.5.3. Market Revenue and Volume Forecast, by Type
12.3.5.4. Market Revenue and Volume Forecast, by End-user
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product
12.3.6.2. Market Revenue and Volume Forecast, by Application
12.3.6.3. Market Revenue and Volume Forecast, by Type
12.3.6.4. Market Revenue and Volume Forecast, by End-user
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product
12.3.7.2. Market Revenue and Volume Forecast, by Application
12.3.7.3. Market Revenue and Volume Forecast, by Type
12.3.7.4. Market Revenue and Volume Forecast, by End-user
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product
12.3.8.2. Market Revenue and Volume Forecast, by Application
12.3.8.3. Market Revenue and Volume Forecast, by Type
12.3.8.4. Market Revenue and Volume Forecast, by End-user
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product
12.4.2. Market Revenue and Volume Forecast, by Application
12.4.3. Market Revenue and Volume Forecast, by Type
12.4.4. Market Revenue and Volume Forecast, by End-user
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product
12.4.5.2. Market Revenue and Volume Forecast, by Application
12.4.5.3. Market Revenue and Volume Forecast, by Type
12.4.5.4. Market Revenue and Volume Forecast, by End-user
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product
12.4.6.2. Market Revenue and Volume Forecast, by Application
12.4.6.3. Market Revenue and Volume Forecast, by Type
12.4.6.4. Market Revenue and Volume Forecast, by End-user
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product
12.4.7.2. Market Revenue and Volume Forecast, by Application
12.4.7.3. Market Revenue and Volume Forecast, by Type
12.4.7.4. Market Revenue and Volume Forecast, by End-user
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product
12.4.8.2. Market Revenue and Volume Forecast, by Application
12.4.8.3. Market Revenue and Volume Forecast, by Type
12.4.8.4. Market Revenue and Volume Forecast, by End-user
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product
12.5.2. Market Revenue and Volume Forecast, by Application
12.5.3. Market Revenue and Volume Forecast, by Type
12.5.4. Market Revenue and Volume Forecast, by End-user
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product
12.5.5.2. Market Revenue and Volume Forecast, by Application
12.5.5.3. Market Revenue and Volume Forecast, by Type
12.5.5.4. Market Revenue and Volume Forecast, by End-user
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product
12.5.6.2. Market Revenue and Volume Forecast, by Application
12.5.6.3. Market Revenue and Volume Forecast, by Type
12.5.6.4. Market Revenue and Volume Forecast, by End-user
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. CYTIVA
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. FUJIFILM Irvine Scientific, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sartorius AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Lonza Group AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. STEMCELL Technologies Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. InvivoGen
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. PromoCell GmbH
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Cell Biologics, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample